U.S. Other Utilities Stock News

Simply Good Foods (SMPL) just posted its Q3 2026 results with revenue of US$357 million and a basic EPS loss of US$0.58, while the trailing twelve months show revenue of about US$1.4 billion and a basic EPS loss of US$2.08. Over recent quarters, revenue has ranged from US$327 million to US$381 million and quarterly basic EPS has shifted between a profit of US$0.41 and a loss of US$1.73, giving investors a clear view of how top line and per share results have moved across the past year. That...

JD.com is facing regulatory scrutiny over alleged false advertising during its 618 shopping festival. China's State Administration for Market Regulation has reportedly become involved in examining the promotion practices. Pomerantz LLP has opened a securities investigation into JD.com related to these allegations. For investors watching NasdaqGS:JD, this inquiry adds a fresh layer of non financial risk to consider alongside the stock’s recent performance. JD.com closed at $28.2, with the...

Ameren stock has delivered a 53.7% return over the past five years, yet its current checks point to an intrinsic value estimate that sits below the market price and a broader valuation profile that does not flag the shares as a clear bargain. Ameren’s 53.7% return over five years highlights that long term holders have already captured a meaningful gain. This can limit the margin of safety if the shares are now priced close to fair value. Recent optimism around earnings consistency and...

PepsiCo (PEP) has just posted Q2 2026 results with revenue of US$24.2 billion and basic EPS of US$2.18, set against trailing 12 month revenue of US$96.9 billion and basic EPS of US$7.65 that came with 3.1% revenue growth and 38.6% earnings growth over the last year. Over recent quarters the company has seen revenue move from US$22.7 billion and EPS of US$0.92 in Q2 2025 to US$24.2 billion and EPS of US$2.18 in Q2 2026. Net profit margin over the last 12 months reached 10.8% compared with 8.2%...

In late June 2026, Solid Biosciences Inc. was added to several Russell growth benchmark indices, including the Russell 2000, 2500, 3000, 3000E, Microcap, and Small Cap Comp Growth indices. This broad index inclusion can expand the company’s reach among institutional investors and index-tracking funds that reference these Russell benchmarks. We’ll now examine how Solid Biosciences’ entry into multiple Russell growth indices may influence its investment narrative and future investor...

On 27 June 2026, Groupon, Inc. was removed from several Russell growth indices and added to multiple Russell value benchmarks, marking a formal reclassification of the stock within these major index families. This broad shift from growth to value indices may influence how institutional investors view Groupon’s profile, potentially affecting index-driven fund positioning and perceptions of its business maturity. We’ll now examine how Groupon’s reclassification into Russell value benchmarks...

Viridian Therapeutics (VRDN) is in focus after the FDA approved Lumvoa for thyroid eye disease, covering both active and chronic forms. This marks the company’s first commercial product and a new chapter for the stock. See our latest analysis for Viridian Therapeutics. The FDA approval has put Viridian Therapeutics back on traders’ radar, with a 30 day share price return of 23.85% and a 90 day share price return of 35.12%. However, the year to date share price return is still down 34.16%,...

With the Federal Reserve keeping rates at 3.5% to 3.75% but signaling a tougher line on inflation, many investors are rethinking where steady income might come from if borrowing costs stay higher for longer. Dividend-paying value stocks with solid balance sheets and moderate payout ratios can look relatively appealing when policy is uncertain and market swings pick up. This article walks through three stocks from a Dividend-Paying Value Stocks screener that appear closely exposed to the...

EU regulators are turning up the heat on social media, and Meta’s clash with the Digital Services Act puts a spotlight on how addictive feed designs and screen-time rules could ripple through the market. Forced product tweaks, potential fines of up to 6% of global turnover, and tighter rules for minors are now real business issues, not distant policy chatter. For investors, that creates both risk and potential opportunity around social media regulation. This article breaks down 3 stocks...

Gaming and Leisure Properties stock has pulled back recently, yet over five years the shares are still ahead and the broader valuation checks lean cheap. This sets up a clear question over whether the latest weakness is offering investors better value or signalling caution. Over the past 5 years, Gaming and Leisure Properties has returned 26.1%, so the current pullback is playing out against a longer record of positive shareholder returns. Recent casino real estate acquisitions can support...

BlackLine, Inc. (NasdaqGS:BL) has opened a new office in Birmingham in the UK, expanding its physical footprint in the region. The new Birmingham site is intended to support BlackLine’s investment in the UK market for financial automation and accounting software. This move is framed as part of the company’s broader international expansion plans and focus on attracting regional talent. BlackLine focuses on cloud software that helps finance and accounting teams automate and manage key...

Dominion Energy (NYSE:D) is drawing increased investor attention as it expands its role in supplying electricity to AI data centers. The company is also involved in a proposed merger with NextEra Energy, which would combine two major U.S. utilities. Together, these developments are putting fresh focus on Dominion Energy’s future business mix and capital needs. Dominion Energy sits at the center of two areas of focus: rising power demand from AI data centers and consolidation among large...

With inflation readings mixed, bond yields reacting to every move in oil and central banks keeping investors guessing, it is easy to feel like markets are all noise and no signal. Founder-led companies offer a different angle. When the person who built the business still sets the tone, incentives can be closely aligned with long term shareholder value, regardless of sector or region. This Founder-Led Companies screener is built to surface leaders who have real skin in the game. In this...

Over the past year, the United States market has experienced a 19% increase, although it remained flat over the past week, with earnings projected to grow by 18% annually in the coming years. In this context of overall growth potential, identifying stocks that are currently trading below their fair value can offer investors opportunities for strong returns while aligning with future earnings expectations.

In the last week, the United States market has been flat, yet over the past 12 months it has risen by 19% with earnings forecasted to grow by 18% annually. In such a robust environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business.

The market in the United States has been flat over the last week, yet it has seen a 19% increase over the past year, with earnings projected to grow by 18% annually. In such a climate, identifying stocks that combine financial strength with growth potential can be particularly rewarding. Despite being an outdated term, penny stocks remain relevant for investors looking for opportunities in smaller or newer companies that offer value and growth where larger firms might not.

Electronic Arts Inc. recently launched EA SPORTS College Football 27 worldwide on PlayStation 5, Xbox Series X|S, and for the first time on PC and mobile, bringing modern college football elements like NIL, coaching movement, and rebuilt Dynasty and Road to Glory modes into a single, fully updated experience. An interesting angle for investors is how College Football 27 extends the college football ecosystem across console, PC, and mobile while linking player legacies directly into Madden...

Bioventus (BVS) is back in the spotlight as company leaders prepare to speak at the 26th Annual New Ideas Summer Investor Conference, giving investors fresh context for the stock’s recent performance. See our latest analysis for Bioventus. That upcoming conference appearance comes after a strong run in Bioventus, with the stock posting a 30 day share price return of 32.83% and a year to date share price return of 69.49%. The 3 year total shareholder return of 231.17% points to momentum that...

In early July 2026, Sunbelt Rentals Holdings completed the private placement of US$450,000,000 4.950% senior notes due 2030 and US$750,000,000 5.650% senior notes due 2036, both senior unsecured and guaranteed by certain subsidiaries. The company plans to deploy the roughly US$1.20 billion in proceeds across debt repayment, capital expenditure and other corporate uses, reshaping its balance sheet and funding capacity. Next, we’ll examine how this benchmark-sized senior notes issuance could...

CBI has filed a chargesheet against Reliance Infrastructure Ltd. and Reliance Home Finance Ltd. in connection with an alleged bank fraud involving Reliance Commercial Finance Ltd. The case centers on alleged fund diversion and wrongful loss to a consortium of public sector banks. The development adds a fresh regulatory angle for investors tracking Reliance Group entities alongside existing business and financing considerations. Reliance operates across infrastructure and financial services,...

Regulatory risk is back in focus as policymakers talk tougher rules, systemic risk safeguards, and tighter oversight just as major economies slow. For investors, that mix can pressure some financial stocks while creating potential openings in areas tied to risk management, compliance, and controls. This article looks at how current headlines intersect with companies that build tools and services to help financial institutions handle regulation and governance. You will see 3 stocks that appear...

Taysha Gene Therapies (TSHA) was recently removed from several Russell indexes, including the Russell 3000E and Russell Microcap families, a change that can influence trading flows as passive funds rebalance. See our latest analysis for Taysha Gene Therapies. Despite the index removals, Taysha Gene Therapies’ recent share price performance has been strong, with a 30 day share price return of 22.57% and a 90 day share price return of 46.33%, while the 1 year total shareholder return sits at a...

Investors who take an interest in Evommune, Inc. ( NYSE:EVMN ) should definitely note that the Independent Director...

The United States market has shown a flat performance over the last week but has experienced a significant rise of 19% over the past year, with earnings expected to grow by 18% annually. In this context, identifying good stocks often involves looking for small-cap companies with potential growth drivers and notable insider activity that may signal confidence in their future prospects.